Bone News and Research

RSS

Abdominal and visceral fat detrimental to bone strength in obese men

Visceral, or deep belly, obesity is a risk factor for bone loss and decreased bone strength in men, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

28 Nov 2012

Gilead Sciences receives EC approval for Viread to treat HIV-1 infected children

Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for two new indications for once-daily Viread (tenofovir disoproxil fumarate).

28 Nov 2012

Joint Implant Surgeons to participate in Operation Walk USA 2012

The physicians of Joint Implant Surgeons are proud to be participating in Operation Walk USA 2012, on December 7th, to provide joint replacement surgeries to patients across the United States who would otherwise be unable to receive appropriate and much needed surgical care due to financial circumstances.

27 Nov 2012

$Fall history can help clinicians determine future risk of fractures$

Fall history can help clinicians determine future risk of fractures

Clinicians are being urged to ask about a patient's history of falls as new research shows that the information is valuable in determining their future risk of fracture.

27 Nov 2012

NEXUS criteria could reduce unnecessary CT scans and spare patients from radiation exposure

A Henry Ford Hospital study has found that better use of commonly accepted diagnostic guidelines for detecting cervical spine injuries could reduce unnecessary CT scans and spare patients from radiation exposure.

27 Nov 2012

FDR AcSelerate integrates Dual Energy Subtraction and Tomosynthesis

FDR AcSelerate, the fully automated positioning DR system from FUJIFILM Medical Systems U.S.A., Inc., will integrate two advanced applications to further extend diagnostic capabilities: Dual Energy Subtraction (DES) and Tomosynthesis (TS).

26 Nov 2012

Medical teams in disaster zones should be prepped to treat children

Emergency medical teams deployed to disaster zones should anticipate a large number of surgical procedures in pediatric patients, particularly those of an orthopedic nature, research suggests.

23 Nov 2012

Well-characterised population cohorts important for clinical decision making

Clinicians are being urged to ask about a patient's history of falls as new research shows that the information is valuable in determining their future risk of fracture.

23 Nov 2012

Lymphopenia driven diseases and the orphan drug industry: an interview with Damian Marron, CEO of Cytheris

Lymphopenia is when you lack the T cells of your immune system. T cells are very important for controlling infection. Probably the most known cause of lymphopenia is HIV.

23 Nov 2012

Osteoporosis medication Aclasta now available on Canadian public drug plans

Osteoporosis Canada congratulates the Ontario government, the New Brunswick government, the Saskatchewan government and the British Columbia government for providing access to a new osteoporosis medication. Aclasta (zoledronic acid) is now available on public and private drug plans in Ontario, BC, SK, and NB meaning Canadians at high risk for fractures have access to increased treatment options.

23 Nov 2012

Belgian FAMHP authorizes C3BS Phase III Congestive Heart failure Cardiopoietic Regenerative Therapy trial

The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiac diseases, today announces it has received authorization from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to begin its Congestive Heart failure Cardiopoietic Regenerative Therapy (CHART-1) European Phase III trial for C3BS-CQR-1 in Belgium.

22 Nov 2012

Study to discover exactly how intravenous immune globulin treatments work

Immune globulin replacement began decades ago as a treatment for patients who could not make their own protective antibodies, but has proven to have much broader benefits than originally expected.

22 Nov 2012

New approach could help orthopaedic surgeons better deal with battlefield injuries

Bones are resilient and heal well after most fractures. But in cases of traumatic injury, in which big pieces of bone are missing, healing is much more difficult, if not impossible. These so-called "large segmental defects" are a major clinical problem, and orthopaedic surgeons struggle to treat them, especially among the military in places like Afghanistan.

22 Nov 2012

No differences between computer-navigated and traditional TKA related to knee function, pain

For many years, the use of computer-assisted navigation has been touted as improving the positioning, sizing and alignment of replacement knee joints, resulting in greater durability of joints and overall improvement in patient movement. However, new research published in the Journal of Bone and Joint Surgery (JBJS) found no difference in knee function, alignment or durability/survivorship between joints positioned and completed with the help of computer navigation, and those replaced with conventional total knee arthroplasty (TKA) procedures.

21 Nov 2012

Acetylon's ective histone deacetylase inhibitors to be showcased at 54th ASH annual meeting

Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its selective histone deacetylase (HDAC) inhibitors will be featured in five posters and one oral presentation at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place December 8-11, 2012, in Atlanta, Georgia.

21 Nov 2012

Researchers discover new gene for susceptibility to Alzheimer's disease

A large-scale international study involving French researchers from the Inserm-Institut Pasteur Lille-Universit- Lille Nord de France "Public health and molecular epidemiology of ageing-related diseases" joint research unit led by Philippe Amouyel, has just discovered a gene for susceptibility to a rare disease that causes susceptibility to a common one, Alzheimer's disease, providing evidence of the heterogeneous aetiology of Alzheimer's disease.

20 Nov 2012

$Digital X-ray radiogrammetry can help identify patients with increased risk of hip fracture$

Digital X-ray radiogrammetry can help identify patients with increased risk of hip fracture

A new study from Karolinska Institutet in Sweden shows, that a technique for measuring bone density called digital X-ray radiogrammetry (or DXR) used on standard hand radiographs can help to identify patients with a higher risk of hip fracture.

20 Nov 2012

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.

19 Nov 2012

Exercise counters negative bone effects of sedentariness in girls

Participation in weight-bearing exercise such as running or football significantly counteracts the effects of sedentary behaviors in adolescent girls, say researchers.

19 Nov 2012

New €6 million European project to address complications associated with diabetes

NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.

19 Nov 2012

Bone News and Research

Abdominal and visceral fat detrimental to bone strength in obese men

Gilead Sciences receives EC approval for Viread to treat HIV-1 infected children

Joint Implant Surgeons to participate in Operation Walk USA 2012

Fall history can help clinicians determine future risk of fractures

NEXUS criteria could reduce unnecessary CT scans and spare patients from radiation exposure

FDR AcSelerate integrates Dual Energy Subtraction and Tomosynthesis

Medical teams in disaster zones should be prepped to treat children

Well-characterised population cohorts important for clinical decision making

Lymphopenia driven diseases and the orphan drug industry: an interview with Damian Marron, CEO of Cytheris

Osteoporosis medication Aclasta now available on Canadian public drug plans

Belgian FAMHP authorizes C3BS Phase III Congestive Heart failure Cardiopoietic Regenerative Therapy trial

Study to discover exactly how intravenous immune globulin treatments work

New approach could help orthopaedic surgeons better deal with battlefield injuries

No differences between computer-navigated and traditional TKA related to knee function, pain

Acetylon's ective histone deacetylase inhibitors to be showcased at 54th ASH annual meeting

Researchers discover new gene for susceptibility to Alzheimer's disease

Digital X-ray radiogrammetry can help identify patients with increased risk of hip fracture

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Exercise counters negative bone effects of sedentariness in girls

New €6 million European project to address complications associated with diabetes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News